Sep 2026· International Journal of Molecular Sciences· Vol 27· 0 citations· 43 references
Medicine
TL;DR
Quantitative proteomics showed that strain genetic background, rather than treatment, was the dominant source of proteome variance, corroborating its phenotypic antibiofilm activity and pointing to compound-specific mechanisms underlying their differential antifungal and antibiofilm effects.
Abstract
Antibiofilm strategies targeting Candida glabrata increasingly focus on membrane-active compounds capable of disrupting biofilm formation and mature biofilm structure. Building on previous work identifying alkylamidobetaine C9 (AAB C9)—[(3-decanoylmethylamino)propyl]dimethylammonium acetate—and β-escin as antibiofilm agents against C. glabrata, this study examined the biochemical and physiological basis of their efficacy in a reference strain (ATCC 90030) and a clinical isolate (2586). Oxidative stress was assessed microscopically after two hours of exposure, and proteome changes were quantified after six hours, for each compound alone and in combination. Fluorescence microscopy showed that AAB C9 and β-escin interacted differently depending on the ROS compartment and strain: in the strain ATCC 90030, the combination antagonized β-escin-induced mitochondrial superoxide, whereas in the multidrug-resistant isolate 2586 it exceeded either agent alone for both cytosolic and mitochondrial superoxide, indicating a strain-dependent, additive interaction. Quantitative proteomics showed that strain genetic background, rather than treatment, was the dominant source of proteome variance. Preranked gene set enrichment analysis revealed that AAB C9 significantly suppressed accumulation of biofilm-formation-associated proteins specifically in isolate 2586, corroborating its phenotypic antibiofilm activity, while β-escin and the combination produced opposing transmembrane-transport signatures, pointing to compound-specific mechanisms underlying their differential antifungal and antibiofilm effects.
Objectives Candida albicans-associated invasive candidiasis exhibits high mortality. Azole resistance and biofilm-mediated persistent infections greatly weaken clinical antifungal efficacy, necessitating new therapeutic approaches. This study investigated the synergistic antifungal and antibiofilm activities of berberi...
Dai-Fan Yue, Dong-Ming Zheng, Zhen Song et al.· Frontiers in Microbiology· 0 citations
Results showed that IBC has potent antifungal activity against C. glabrata (MIC: 4-5 μg/mL), including both the standard strain and clinical isolates, and indicated that IBC is a promising antifungal candidate for treating C. glabrata infections.
Longfei Yang, Yan-Feng Zhang, Yu Zhang et al.· Frontiers in Cellular and In...· 0 citations
Findings support a working model in which iron limitation-associated physiological stress contributes to the inhibitory effects of taxifolin on C. perfringens growth and colonization-related phenotypes and support its potential use as a plant-derived approach for limiting C. perfringens intestinal colonization.
H. Fadhilatunnur, Weichen Gong, Haruna Sato et al.· Microbiology spectrum· 0 citations
Sabinene exhibits promising activity as a natural anti-virulence candidate that attenuates quorum sensing and biofilm-associated virulence factors in P. aeruginosa, warranting further investigation into its therapeutic potential.
This in vitro study evaluated the efficacy of Zerumbone (ZER), a sesquiterpene phytochemical extracted from the rhizomes of Zingiber zerumbet (L.) Smith with reported antimicrobial properties, alone or combined with Dextranase (DEX) and DNase I (DNase), against polymicrobial biofilms of fluconazole-susceptible and fluc...
A. D. de Oliveira, B. H. D. Panariello, P. A. Barbugli et al.· ACS Omega· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.